BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7869464)

  • 1. Financing and cost of standard and enhanced methadone treatment.
    Bradley CJ; French MT; Rachal JV
    J Subst Abuse Treat; 1994; 11(5):433-42. PubMed ID: 7869464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining variation in treatment costs: a cost function for outpatient methadone treatment programs.
    Dunlap LJ; Zarkin GA; Cowell AJ
    Health Serv Res; 2008 Jun; 43(3):931-50. PubMed ID: 18454774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methadone maintenance programs with supplementary services: a cost-effectiveness study].
    Puigdollers E; Cots F; Brugal MT; Torralba L; Domingo-Salvany A
    Gac Sanit; 2003; 17(2):123-30. PubMed ID: 12729539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial factors and the implementation of medications for treating opioid use disorders.
    Knudsen HK; Roman PM
    J Addict Med; 2012 Dec; 6(4):280-6. PubMed ID: 22810057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Users of free treatment slots at a community-based methadone maintenance clinic.
    Wells EA; Fleming C; CalsyƄ DA; Jackson TR; Saxon AJ
    J Subst Abuse Treat; 1995; 12(1):13-8. PubMed ID: 7752292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.
    Burgos JL; Cepeda JA; Kahn JG; Mittal ML; Meza E; Lazos RRP; Vargas PC; Vickerman P; Strathdee SA; Martin NK
    Harm Reduct J; 2018 May; 15(1):28. PubMed ID: 29792191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP).
    French MT; Dunlap LJ; Zarkin GA; McGeary KA; McLellan AT
    J Subst Abuse Treat; 1997; 14(5):445-55. PubMed ID: 9437614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Program changes and retention on methadone.
    Maddux JF; Vogtsberger KN; Desmond DP; Esquivel M
    J Subst Abuse Treat; 1993; 10(6):585-8. PubMed ID: 8308944
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are supplementary services provided during methadone maintenance really cost-effective?
    Kraft MK; Rothbard AB; Hadley TR; McLellan AT; Asch DA
    Am J Psychiatry; 1997 Sep; 154(9):1214-9. PubMed ID: 9286179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia.
    Afriandi I; Siregar AY; Meheus F; Hidayat T; van der Ven A; van Crevel R; Baltussen R
    Health Policy; 2010 Apr; 95(1):69-73. PubMed ID: 20004491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system.
    Chalmers J; Ritter A
    Drug Alcohol Rev; 2012 Nov; 31(7):911-7. PubMed ID: 22624529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid substitution: improving cost-efficiency.
    Sullivan S
    Bull World Health Organ; 2013 Feb; 91(2):83. PubMed ID: 23554517
    [No Abstract]   [Full Text] [Related]  

  • 17. Retention in publicly funded methadone maintenance treatment in two Western States.
    Deck D; Carlson MJ
    J Behav Health Serv Res; 2005; 32(1):43-60. PubMed ID: 15632797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam.
    Vuong T; Shanahan M; Nguyen N; Le G; Ali R; Pham K; Vuong TTA; Dinh T; Ritter A
    Drug Alcohol Depend; 2016 Nov; 168():147-155. PubMed ID: 27664552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits.
    Herbst MD; Batki SL; Manfredi LB; Jones T
    Psychiatr Serv; 1996 Feb; 47(2):119-20, 142. PubMed ID: 8825244
    [No Abstract]   [Full Text] [Related]  

  • 20. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
    Healey A; Knapp M; Marsden J; Gossop M; Stewart D
    J Health Serv Res Policy; 2003 Jul; 8(3):134-41. PubMed ID: 12869338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.